E. Regañón

481 total citations
28 papers, 400 citations indexed

About

E. Regañón is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, E. Regañón has authored 28 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in E. Regañón's work include Blood properties and coagulation (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Transplantation: Methods and Outcomes (4 papers). E. Regañón is often cited by papers focused on Blood properties and coagulation (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Transplantation: Methods and Outcomes (4 papers). E. Regañón collaborates with scholars based in Spain, United States and Slovakia. E. Regañón's co-authors include V. Vila, A. Estellés, José A. Aznar, Francisco España, J Aznar, Luis Ramón, M. Chirivella, Vicenta Martı́nez-Sales, Remedios Castelló and Juan Gilabert–Estellés and has published in prestigious journals such as Journal of Clinical Oncology, Human Reproduction and Clinica Chimica Acta.

In The Last Decade

E. Regañón

26 papers receiving 383 citations

Peers

Countries citing papers authored by E. Regañón

Since Specialization

Citations

This map shows the geographic impact of E. Regañón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Regañón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Regañón more than expected).

Fields of papers citing papers by E. Regañón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Regañón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Regañón. The network helps show where E. Regañón may publish in the future.

Co-authorship network of co-authors of E. Regañón

This figure shows the co-authorship network connecting the top 25 collaborators of E. Regañón. A scholar is included among the top collaborators of E. Regañón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Regañón. E. Regañón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer 2013 ·Clinical & Translational Oncology ·Tania Fleitas, Vicenta Martı́nez-Sales, V. Vila, E. Regañón, (unknown), (unknown), José Gómez‐Codina, Joaquín Montalar, Gaspar Reynés	28
2	Circulating endothelial cells, microparticles, and markers of inflammation and coagulation in glioblastoma patients before and after protracted temozolomide and radiotherapy. 2010 ·Journal of Clinical Oncology ·Gaspar Reynés, Vicenta Martı́nez-Sales, V. Vila, Tania Fleitas, Michael G. Martin, E. Regañón	1
3	What is the best biomarker for diagnosis of rejection in heart transplantation? 2009 ·Clinical Transplantation ·Luis Martínez‐Dolz, Luís Almenar, E. Regañón, V. Vila, (unknown), Vicenta Martı́nez-Sales, J. Moro, Jaume Agüero, Ignacio Sánchez‐Lázaro, A. Salvador	23
4	Follow-up Study on the Utility of von Willebrand Factor Levels in the Diagnosis of Cardiac Allograft Vasculopathy 2008 ·The Journal of Heart and Lung Transplantation ·Luis Martínez‐Dolz, Luís Almenar, E. Regañón, Virtudes Vila, (unknown), (unknown), Vicenta Martı́nez-Sales, J. Moro, Jaume Agüero, Ignacio Sánchez‐Lázaro, Antonio Salvador	21
5	Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems 2007 ·Human Reproduction ·Juan Gilabert–Estellés, Luis Ramón, Francisco España, V. Vila, E. Regañón, Remedios Castelló, M. Chirivella, A. Estellés	112
6	Usefulness of von Willebrand Factor in Cardiac Allograft Vasculopathy: Preliminary Experience 2006 ·Transplantation Proceedings ·(unknown), Luís Almenar, Luis Martínez‐Dolz, E. Regañón, (unknown), Paola Villa, (unknown), (unknown), Vicenta Martı́nez-Sales, A. Salvador	4
7	Diagnostic Usefulness of Inflammatory Markers in Acute Cellular Rejection After Heart Transplantation 2006 ·Transplantation Proceedings ·(unknown), Luís Almenar, Luis Martínez‐Dolz, E. Regañón, Vicenta Martı́nez-Sales, (unknown), V. Vila, (unknown), Paola Villa, A. Salvador	7
8	La atorvastaina modula a la trombospondina en células endoteliales umbilicales humanas 2005 ·Clínica e Investigación en Arteriosclerosis ·Vicenta Martı́nez-Sales, V. Vila, E. Regañón, (unknown), (unknown)	0
9	Elevated Thrombotic Activity after Myocardial Infarction: A 2-Year Follow-Up Study 1998 ·Pathophysiology of Haemostasis and Thrombosis ·Vicenta Martı́nez-Sales, V. Vila, E. Regañón, (unknown), Fernando Ferrando, (unknown), J Aznar	24
10	Increase in Thrombin Generation after Coronary Thrombolysis with rt-PA or Streptokinase with Simultaneous Heparin versus Heparin Alone 1998 ·Pathophysiology of Haemostasis and Thrombosis ·E. Regañón, Fernando Ferrando, V. Vila, Paola Villa, Vicenta Martı́nez-Sales, (unknown), (unknown), J Aznar	5
11	Decreased High-Molecular Weight Fibrinogen and Impaired Alpha-Chain Polymerization in Full-Term Newborns 1993 ·Pathophysiology of Haemostasis and Thrombosis ·E. Regañón, V. Vila, Begoña Laíz, J. Gilabert, J Aznar	7
12	Congenital Hypofibrinogenemia and Pregnancy, Obstetric and Hematological Management 1987 ·Gynecologic and Obstetric Investigation ·J. Gilabert, E. Regañón, V. Vila, (unknown), Pia Villa, J Aznar, (unknown)	9
13	Characterization of fibrinogen Barcelona 1 (FB): Congenital dysfibrinogenemia with defective release of fibrinopeptide A and abnormal plasmic degradation 1986 ·Thrombosis Research ·V. Vila, E. Regañón, José A. Aznar, Gemma Navarro, M. Salas	1
14	A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6,000 1985 ·Thrombosis Research ·V. Vila, E. Regañón, (unknown), J Aznar	15
15	Gelation of Fibrinogen in Plasma 1984 ·Pathophysiology of Haemostasis and Thrombosis ·E. Regañón, V. Vila, José A. Aznar	14
16	Effect of calcium ions on fibrin gel formation in normal plasma 1984 ·Thrombosis Research ·E. Regañón, V. Vila, José A. Aznar	6
17	Inherited Fibrinolytic Disorder Due to an Enhanced Plasminogen Activator Level 1984 ·Thrombosis and Haemostasis ·J Aznar, A. Estellés, V. Vila, E. Regañón, Francisco España, Paola Villa	29
18	Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study 1984 ·Scandinavian Journal of Haematology ·V. Vila, E. Regañón, (unknown), J Aznar	2
19	Isolation of fibrin(OGEN) degradation products from normal plasma by affinity chromatographic study 1978 ·Clinica Chimica Acta ·V. Vila, E. Regañón, José A. Aznar	6
20	Degradation of human fibrinogen by plasmin: A kinetic study 1977 ·Thrombosis Research ·E. Regañón, José A. Aznar, V. Vila	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact